Clinical trial
Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery: A Randomized Controlled Trial
NCT07569614 is registered in ClinicalTrials.gov with First Affiliated Hospital of Kunming Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effects of Remimazolam Tosylate and Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery: A Randomized Controlled Trial
- Lead sponsor
- First Affiliated Hospital of Kunming Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2025
- Completion date
- February 1, 2026
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dexmedetomidine, postoperative delirium (pod), remimazolam besylate, thoracoscopic surgery